Answers are grounded in this paper and cite their sources.
Functional precision medicine represents a promising approach to address the biological heterogeneity and therapeutic complexity of leukemias. By integrating direct functional assessment of drug response with molecular and clinical information, this strategy provides a more comprehensive framework for individualized therapy selection. Although important challenges remain, including methodological standardization, limited viability of primary leukemic cells, high infrastructure costs, and the need for prospective clinical validation, ongoing technological and computational advances are expected to facilitate broader clinical implementation. Ultimately, functional precision medicine may become a central component of modern hematologic oncology, enabling more dynamic, biologically informed, and patient-centered therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Mariano et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: